$GTCH
GBT Technologies Inc. Stock $gtch

$gtch Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-Q Financial Statement

#000173112222001969 Filed on November 14, 2022

Income Statement

Concept	2022 Q4	2022 Q3	2021 Q4
Revenue	$336.1K	$246.5K	$45.00K
YoY Change	646.91%	447.77%	0.0%
Cost Of Revenue	$287.8K	$141.5K
YoY Change
Gross Profit	$48.36K	$105.0K
YoY Change		133.22%
Gross Profit Margin	14.39%	42.58%
Selling, General & Admin	$661.9K	$255.3K	$808.7K
YoY Change	-18.15%	-71.83%	-14.71%
% of Gross Profit	1368.65%	243.27%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization			$0.00
YoY Change
% of Gross Profit
Operating Expenses	$611.9K	$633.5K	$808.7K
YoY Change	-24.33%	-30.1%	-14.71%
Operating Profit	-$563.5K	-$528.6K
YoY Change		-38.64%
Interest Expense	$3.460M	$261.9K	-$1.860M
YoY Change	-286.01%	221.46%	-39.26%
% of Operating Profit
Other Income/Expense, Net	$172.1K	$2.299M	$1.548M
YoY Change	-88.88%	556.87%
Pretax Income	$3.068M	$1.770M	-$1.076M
YoY Change	-385.09%	-511.8%	-73.53%
Income Tax			$0.00
% Of Pretax Income
Net Earnings	$3.068M	$1.770M	-$1.076M
YoY Change	-385.09%	-511.8%	-73.53%
Net Earnings / Revenue	912.88%	718.26%	-2391.64%
Basic Earnings Per Share		$0.00
Diluted Earnings Per Share	$0.00	$0.00	-$35.41K
COMMON SHARES
Basic Shares Outstanding	1.207B shares	1.108B shares
Diluted Shares Outstanding		5.198B shares

Balance Sheet

Concept	2022 Q4	2022 Q3	2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$122.8K	$130.9K	$268.1K
YoY Change	-54.17%	-76.82%	-76.98%
Cash & Equivalents	$93.58K	$89.96K	$155.1K
Short-Term Investments	$16.20K	$40.94K	$0.00
Other Short-Term Assets	$125.4K	$127.2K
YoY Change
Inventory	$11.57K	$7.158K
Prepaid Expenses
Receivables	$25.24K	$19.23K
Other Receivables	$198.5K	$224.9K
Total Short-Term Assets	$370.6K	$861.4K	$4.018M
YoY Change	-90.78%	-51.19%	245.02%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$0.00	$0.00	$0.00
YoY Change		-100.0%
TOTAL ASSETS
Total Short-Term Assets	$370.6K	$861.4K	$4.018M
Total Long-Term Assets	$0.00	$0.00	$0.00
Total Assets	$370.6K	$861.4K	$4.018M
YoY Change	-90.78%	-70.94%	245.02%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.531M	$1.089M	$1.110M
YoY Change	37.89%	-13.29%	6.15%
Accrued Expenses	$1.513M	$660.7K	$9.876M
YoY Change	-84.68%	-90.01%
Deferred Revenue	$41.44K	$43.94K	$0.00
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change			-100.0%
Long-Term Debt Due	$6.695M	$6.845M	$10.98M
YoY Change	-39.01%	112.4%	-18.23%
Total Short-Term Liabilities	$18.89M	$22.92M	$32.41M
YoY Change	-41.7%	-2.35%	12.23%
LONG-TERM LIABILITIES
Long-Term Debt	$308.9K	$311.8K	$373.4K
YoY Change	-17.28%	-96.29%	151.85%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$308.9K	$311.8K	$373.4K
YoY Change	-17.28%	-96.29%	151.85%
TOTAL LIABILITIES
Total Short-Term Liabilities	$18.89M	$22.92M	$32.41M
Total Long-Term Liabilities	$308.9K	$311.8K	$373.4K
Total Liabilities	$19.20M	$23.23M	$32.78M
YoY Change	-41.42%	-27.12%	12.95%
SHAREHOLDERS EQUITY
Retained Earnings	-$299.3M	-$302.3M	-$304.6M
YoY Change	-1.75%
Common Stock	$15.36K	$11.84K	$332.00
YoY Change	4525.3%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$643.1K	$643.1K	$643.1K
YoY Change	0.0%
Treasury Stock Shares		21.00 shares	21.00 shares
Shareholders Equity	-$18.83M	-$22.37M	-$28.76M
YoY Change
Total Liabilities & Shareholders Equity	$370.6K	$861.4K	$4.018M
YoY Change	-90.78%	-70.94%	245.02%

Cashflow Statement

Concept	2022 Q4	2022 Q3	2021 Q4
OPERATING ACTIVITIES
Net Income	$3.068M	$1.770M	-$1.076M
YoY Change	-385.09%	-511.8%	-73.53%
Depreciation, Depletion And Amortization			$0.00
YoY Change
Cash From Operating Activities	-$471.7K	$98.08K	-$411.1K
YoY Change	14.74%	-949.18%	-8.95%
INVESTING ACTIVITIES
Capital Expenditures			$0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	$0.00
YoY Change
Cash From Investing Activities	$0.00	$0.00	$0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	53.01K	-37.18K	179.5K
YoY Change	-70.48%	-109.79%	-42.54%
NET CHANGE
Cash From Operating Activities	-471.7K	98.08K	-411.1K
Cash From Investing Activities	0.000	0.000	0.000
Cash From Financing Activities	53.01K	-37.18K	179.5K
Net Change In Cash	-418.7K	60.90K	-231.6K
YoY Change	80.82%	-83.46%	66.56%
FREE CASH FLOW
Cash From Operating Activities	-$471.7K	$98.08K	-$411.1K
Capital Expenditures			$0.00
Free Cash Flow			-$411.1K
YoY Change			-8.95%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q3	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent		usd
	dei	Entity Central Index Key EntityCentralIndexKey	0001471781
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
CY2021Q4	us-gaap	Escrow Deposit EscrowDeposit		usd
CY2022Q3	us-gaap	Assets Held In Trust Current AssetsHeldInTrustCurrent		usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent		usd
CY2021Q4	us-gaap	Inventory Net InventoryNet		usd
CY2021Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent		usd
CY2021Q4	us-gaap	Due From Related Parties DueFromRelatedParties		usd
CY2021Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent		usd
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability		usd
CY2022Q3	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent		usd
CY2021Q3	gtch	Sales Sales		usd
	gtch	Sales Sales		usd
CY2021Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold		usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold		usd
CY2021Q3	us-gaap	Acquisition Costs AcquisitionCosts		usd
	us-gaap	Acquisition Costs AcquisitionCosts		usd
CY2022Q3	us-gaap	Asset Impairment Charges AssetImpairmentCharges		usd
CY2021Q3	us-gaap	Asset Impairment Charges AssetImpairmentCharges		usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges		usd
CY2022Q3	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss		usd
CY2021Q3	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss		usd
	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss		usd
CY2022Q3	us-gaap	Gains Losses On Restructuring Of Debt GainsLossesOnRestructuringOfDebt		usd
CY2021Q3	us-gaap	Gains Losses On Restructuring Of Debt GainsLossesOnRestructuringOfDebt		usd
	us-gaap	Gains Losses On Restructuring Of Debt GainsLossesOnRestructuringOfDebt		usd
CY2021Q3	gtch	Gain On Rjw Settlement GainOnRjwSettlement		usd
	gtch	Gain On Rjw Settlement GainOnRjwSettlement		usd
CY2022Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2021Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2021Q3	gtch	Change In Fair Value Of Marketable Securities ChangeInFairValueOfMarketableSecurities		usd
	gtch	Change In Fair Value Of Marketable Securities ChangeInFairValueOfMarketableSecurities		usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q2	gtch	Common Stock Issued For Jv Tokenize CommonStockIssuedForJvTokenize		usd
CY2022Q2	gtch	Equity Method Investment Meta EquityMethodInvestmentMeta		usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims		usd
CY2022Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues		usd
CY2022Q3	gtch	Common Stock Issued For Jv Tokenize CommonStockIssuedForJvTokenize		usd
CY2022Q3	gtch	Equity Method Investment Meta EquityMethodInvestmentMeta		usd
	us-gaap	Gains Losses On Restructuring Of Debt GainsLossesOnRestructuringOfDebt		usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges		usd
	us-gaap	Realized Gain Loss On Marketable Securities Cost Method Investments And Other Investments RealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestments		usd
	gtch	Payment Of Other Income With Marketable Securities PaymentOfOtherIncomeWithMarketableSecurities		usd
	gtch	Change In Fair Value Of Marketable Securitie ChangeInFairValueOfMarketableSecuritie		usd
	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement		usd
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables		usd
	gtch	Increase Decrease In Inventory In Transit IncreaseDecreaseInInventoryInTransit		usd
	gtch	Increase Decrease In Cash Held In Trust IncreaseDecreaseInCashHeldInTrust		usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories		usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue		usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability		usd
	gtch	Investment To Gtx InvestmentToGtx		usd
	gtch	Investment To Tghi InvestmentToTghi		usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
	gtch	Issuance Of Note Receivable IssuanceOfNoteReceivable		usd
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity		usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt		usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt		usd
	us-gaap	Interest Paid InterestPaid		usd
	us-gaap	Interest Paid InterestPaid		usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
	gtch	Equity Method Investment EquityMethodInvestment		usd
	gtch	Share Issuance For Jv Metaverse ShareIssuanceForJvMetaverse		usd
	gtch	Share Issuance For Jv Tokenize ShareIssuanceForJvTokenize		usd
CY2022Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent		usd
	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1		shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount		shares
CY2022Q3	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable		usd
CY2022Q3	gtch	Convertible Notes Payable Net Related Party Longterm Portion ConvertibleNotesPayableNetRelatedPartyLongtermPortion		usd
CY2021Q4	gtch	Convertible Notes Payable Net Related Party Longterm Portion ConvertibleNotesPayableNetRelatedPartyLongtermPortion		usd
CY2022Q3	gtch	Notes Payable Net Related Party Longterm Portion NotesPayableNetRelatedPartyLongtermPortion		usd
CY2021Q4	gtch	Notes Payable Net Related Party Longterm Portion NotesPayableNetRelatedPartyLongtermPortion		usd
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding		usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted		shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod		shares
CY2022Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding		usd
CY2022Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-54530
	dei	Entity Registrant Name EntityRegistrantName	GBT TECHNOLOGIES INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	27-0603137
	dei	Entity Address Address Line1 EntityAddressAddressLine1	2450 Colorado Ave.
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 100E
	dei	Entity Address City Or Town EntityAddressCityOrTown	Santa Monica
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	90404
	dei	City Area Code CityAreaCode	888
	dei	Local Phone Number LocalPhoneNumber	685-7336
CY2022Q3	us-gaap	Escrow Deposit EscrowDeposit	394694	usd
CY2021Q4	us-gaap	Assets Held In Trust Current AssetsHeldInTrustCurrent	112942	usd
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	1206818392	shares
CY2022Q3	us-gaap	Cash Cash	130642	usd
CY2021Q4	us-gaap	Cash Cash	155106	usd
CY2022Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	19227	usd
CY2022Q3	us-gaap	Inventory Net InventoryNet	7158	usd
CY2022Q3	us-gaap	Receivables Net Current ReceivablesNetCurrent	194821	usd
CY2021Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	3750000	usd
CY2022Q3	us-gaap	Other Inventory In Transit OtherInventoryInTransit	43872	usd
CY2022Q3	us-gaap	Due From Related Parties DueFromRelatedParties	30049	usd
CY2022Q3	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	40942	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	861405	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	4018048	usd
CY2022Q3	us-gaap	Assets Assets	861405	usd
CY2021Q4	us-gaap	Assets Assets	4018048	usd
CY2022Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	5901663	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	6896263	usd
CY2022Q3	gtch	Accrued Settlement AccruedSettlement	4090057	usd
CY2021Q4	gtch	Accrued Settlement AccruedSettlement	4090057	usd
CY2022Q3	us-gaap	Unearned Premiums UnearnedPremiums	249159	usd
CY2021Q4	us-gaap	Unearned Premiums UnearnedPremiums	249384	usd
CY2022Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	43944	usd
CY2022Q3	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	6549832	usd
CY2021Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	8109436	usd
CY2022Q3	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	116605	usd
CY2021Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	116605	usd
CY2022Q3	us-gaap	Notes Payable Current NotesPayableCurrent	38196	usd
CY2021Q4	us-gaap	Notes Payable Current NotesPayableCurrent	2612397	usd
CY2022Q3	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	140000	usd
CY2021Q4	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	140000	usd
CY2022Q3	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	5787760	usd
CY2021Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	10192485	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	22917216	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	32406629	usd
CY2022Q3	us-gaap	Debt Instrument Unamortized Discount Noncurrent DebtInstrumentUnamortizedDiscountNoncurrent	0	usd
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount Noncurrent DebtInstrumentUnamortizedDiscountNoncurrent	88403	usd
CY2021Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	35797	usd
CY2022Q3	us-gaap	Long Term Notes Payable LongTermNotesPayable	311804	usd
CY2021Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	337603	usd
CY2022Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	311804	usd
CY2021Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	373400	usd
CY2022Q3	us-gaap	Liabilities Liabilities	23229020	usd
CY2021Q4	us-gaap	Liabilities Liabilities	32780029	usd
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2021Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	21	shares
CY2022Q3	us-gaap	Treasury Stock Value TreasuryStockValue	643059	usd
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	2000000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	2000000000	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1183741469	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1183741469	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5133489	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5133489	shares
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	11838	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	332	usd
CY2022Q3	us-gaap	Treasury Stock Shares TreasuryStockShares	21	shares
CY2021Q4	us-gaap	Treasury Stock Value TreasuryStockValue	643059	usd
CY2022Q3	gtch	Stock Loan Receivable StockLoanReceivable	-7610147	usd
CY2021Q4	gtch	Stock Loan Receivable StockLoanReceivable	-7610147	usd
CY2022Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	288199959	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	284072666	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-302326206	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-304581773	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-22367615	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-28761981	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	861405	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4018048	usd
CY2022Q3	gtch	Sales Sales	201495	usd
	gtch	Sales Sales	771446	usd
CY2022Q3	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	45000	usd
CY2021Q3	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	45000	usd
	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	90000	usd
	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	135000	usd
CY2022Q3	us-gaap	Revenues Revenues	246495	usd
CY2021Q3	us-gaap	Revenues Revenues	45000	usd
	us-gaap	Revenues Revenues	861446	usd
	us-gaap	Revenues Revenues	135000	usd
CY2022Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	141545	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	530003	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	104950	usd
CY2021Q3	us-gaap	Gross Profit GrossProfit	45000	usd
	us-gaap	Gross Profit GrossProfit	331443	usd
	us-gaap	Gross Profit GrossProfit	135000	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	167411	usd
CY2021Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	723706	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	538663	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1931963	usd
CY2022Q3	us-gaap	Marketing Expense MarketingExpense	87900	usd
CY2021Q3	us-gaap	Marketing Expense MarketingExpense	182692	usd
	us-gaap	Marketing Expense MarketingExpense	521200	usd
	us-gaap	Marketing Expense MarketingExpense	514906	usd
CY2022Q3	us-gaap	Acquisition Costs AcquisitionCosts	378226	usd
	us-gaap	Acquisition Costs AcquisitionCosts	1506418	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	15400000	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	633537	usd
CY2021Q3	us-gaap	Operating Expenses OperatingExpenses	906398	usd
	us-gaap	Operating Expenses OperatingExpenses	2566281	usd
	us-gaap	Operating Expenses OperatingExpenses	17846869	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-528587	usd
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-861398	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2234838	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-17711869	usd
CY2022Q3	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	54132	usd
CY2021Q3	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	220095	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	362011	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	686732	usd
CY2022Q3	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	-354869	usd
CY2021Q3	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	627784	usd
	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	2795870	usd
	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	-165402	usd
CY2022Q3	us-gaap	Interest Expense InterestExpense	261858	usd
CY2021Q3	us-gaap	Interest Expense InterestExpense	326222	usd
	us-gaap	Interest Expense InterestExpense	731251	usd
	us-gaap	Interest Expense InterestExpense	1473712	usd
	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	11000	usd
	us-gaap	Gains Losses On Restructuring Of Debt GainsLossesOnRestructuringOfDebt	-13777480	usd
CY2022Q3	gtch	Gain On Rjw Settlement GainOnRjwSettlement	3012633	usd
	gtch	Gain On Rjw Settlement GainOnRjwSettlement	3012633	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	50000	usd
CY2022Q3	gtch	Change In Fair Value Of Marketable Securities ChangeInFairValueOfMarketableSecurities	50537	usd
	gtch	Change In Fair Value Of Marketable Securities ChangeInFairValueOfMarketableSecurities	290537	usd
CY2022Q3	gtch	Licensing Income Related Party LicensingIncomeRelatedParty	7814	usd
CY2021Q3	gtch	Licensing Income Related Party LicensingIncomeRelatedParty	350000	usd
	gtch	Licensing Income Related Party LicensingIncomeRelatedParty	15699	usd
	gtch	Licensing Income Related Party LicensingIncomeRelatedParty	950000	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2299051	usd
CY2021Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	431467	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	4490403	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-15142326	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1770464	usd
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-429931	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2255565	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-32854195	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	1770464	usd
CY2021Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-429931	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	2255565	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-32854195	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	1770464	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-429931	usd
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
	us-gaap	Net Income Loss NetIncomeLoss	2255565	usd
	us-gaap	Net Income Loss NetIncomeLoss	-32854195	usd
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1108371904	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	26154579	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1426061998	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16522673	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5198401226	shares
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	26154579	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5516091320	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	16522673	shares
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.99
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.99
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-28761981	usd
CY2022Q1	gtch	Common Stock Issued For Conversion Of Convertible Debt And Accrued Interest CommonStockIssuedForConversionOfConvertibleDebtAndAccruedInterest	35000	usd
CY2022Q1	us-gaap	Debt Instrument Convertible Beneficial Conversion Feature DebtInstrumentConvertibleBeneficialConversionFeature	49504	usd
CY2022Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	68308	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	3926239	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-24682930	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	1666861	usd
CY2022Q2	gtch	Fair Value Of Derivative Liability Due To Conversions FairValueOfDerivativeLiabilityDueToConversions	1571238	usd
CY2022Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	163559	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	-3441137	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-24722409	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	270300	usd
CY2022Q3	gtch	Fair Value Of Derivative Liability Due To Conversions FairValueOfDerivativeLiabilityDueToConversions	314029	usd
CY2022Q3	us-gaap	Profit Loss ProfitLoss	1770464	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-22367615	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-27858303	usd
CY2021Q1	gtch	Common Stock Issued For Conversion Of Convertible Debt And Accrued Interest CommonStockIssuedForConversionOfConvertibleDebtAndAccruedInterest	3122848	usd
CY2021Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	281750	usd
CY2021Q1	us-gaap	Debt Instrument Convertible Beneficial Conversion Feature DebtInstrumentConvertibleBeneficialConversionFeature	9207107	usd
CY2021Q1	us-gaap	Profit Loss ProfitLoss	-5375609	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	-20622207	usd
CY2021Q2	gtch	Common Stock Issued For Conversion Of Convertible Debt And Accrued Interest CommonStockIssuedForConversionOfConvertibleDebtAndAccruedInterest	592705	usd
CY2021Q2	gtch	Common Stock Issued For Joint Venture CommonStockIssuedForJointVenture	15400000	usd
CY2021Q2	us-gaap	Debt Instrument Convertible Beneficial Conversion Feature DebtInstrumentConvertibleBeneficialConversionFeature	522349	usd
CY2021Q2	us-gaap	Profit Loss ProfitLoss	-27048655	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	-31155808	usd
CY2021Q3	gtch	Common Stock Issued For Conversion Of Convertible Debt And Accrued Interest CommonStockIssuedForConversionOfConvertibleDebtAndAccruedInterest	1540457	usd
CY2021Q3	gtch	Common Stock Issued For Joint Venture CommonStockIssuedForJointVenture	1135462	usd
CY2021Q3	us-gaap	Debt Instrument Convertible Beneficial Conversion Feature DebtInstrumentConvertibleBeneficialConversionFeature	522349	usd
CY2021Q3	us-gaap	Profit Loss ProfitLoss	-429931	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	-28387471	usd
	us-gaap	Net Income Loss NetIncomeLoss	2255565	usd
	us-gaap	Net Income Loss NetIncomeLoss	-32854195	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	362011	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	686732	usd
	gtch	Change In Fair Value Of Derivative Liability ChangeInFairValueOfDerivativeLiability	-2795870	usd
	gtch	Change In Fair Value Of Derivative Liability ChangeInFairValueOfDerivativeLiability	165402	usd
	gtch	Excess Of Debt Discount And Financing Costs ExcessOfDebtDiscountAndFinancingCosts	34175	usd
	gtch	Excess Of Debt Discount And Financing Costs ExcessOfDebtDiscountAndFinancingCosts	609265	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	281750	usd
	us-gaap	Gains Losses On Restructuring Of Debt GainsLossesOnRestructuringOfDebt	-13777480	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	15400000	usd
	us-gaap	Realized Gain Loss On Marketable Securities Cost Method Investments And Other Investments RealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestments	11000	usd
	gtch	Payment Of Other Income With Marketable Securities PaymentOfOtherIncomeWithMarketableSecurities	800000	usd
	gtch	Change In Fair Value Of Marketable Securitie ChangeInFairValueOfMarketableSecuritie	290538	usd
	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	3012633	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	19227	usd
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-3745179	usd
	gtch	Increase Decrease In Inventory In Transit IncreaseDecreaseInInventoryInTransit	43872	usd
	gtch	Increase Decrease In Cash Held In Trust IncreaseDecreaseInCashHeldInTrust	224516	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	7158	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-225	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-6056	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-469014	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1562039	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	333414	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-958011	usd
	gtch	Investment To Gtx InvestmentToGtx	150000	usd
	gtch	Investment To Tghi InvestmentToTghi	125000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-275000	usd
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	300000	usd
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	1231636	usd
	gtch	Issuance Of Note Receivable IssuanceOfNoteReceivable	190000	usd
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	231864	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	664225	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	634176	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	311816	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1231636	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	370230	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	273625	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	155106	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	113034	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	525336	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	386659	usd
	gtch	Debt Discount Related To Convertible Debt DebtDiscountRelatedToConvertibleDebt	325916	usd
	gtch	Debt Discount Related To Convertible Debt DebtDiscountRelatedToConvertibleDebt	641100	usd
	gtch	Reduction In Derivative Liability Due To Conversion ReductionInDerivativeLiabilityDueToConversion	1934771	usd
	gtch	Reduction In Derivative Liability Due To Conversion ReductionInDerivativeLiabilityDueToConversion	10864918	usd
	gtch	Working Capital Deficit WorkingCapitalDeficit	22055811	usd
	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1-for-500
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-302326206	usd
	gtch	Shares Issued For Conversion Of Convertible Debt SharesIssuedForConversionOfConvertibleDebt	1972164	usd
	gtch	Shares Issued For Conversion Of Convertible Debt SharesIssuedForConversionOfConvertibleDebt	5256010	usd
	gtch	Equity Method Investment EquityMethodInvestment	424731	usd
	gtch	Share Issuance For Jv Metaverse ShareIssuanceForJvMetaverse	5000	usd
	gtch	Share Issuance For Jv Tokenize ShareIssuanceForJvTokenize	1500	usd
	gtch	Transfer Of Accounts Payable To Convertible Note TransferOfAccountsPayableToConvertibleNote	424731	usd
	gtch	Transfer Of Accounts Payable To Convertible Notes TransferOfAccountsPayableToConvertibleNotes	202899	usd
CY2021Q4	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1 for 50
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	2000000000	shares
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84D_eus-gaap--UseOfEstimates_z1eXhKLNJ4Ra" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_86B_zLCAgXZzVcda">Use of Estimates</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of CFS in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the CFS and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected. Significant estimates in the accompanying financial statements include leases, valuation of derivatives and valuation allowance on deferred tax assets.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2022Q3	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2021Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2022Q3	us-gaap	Restricted Cash Equivalents RestrictedCashEquivalents	375000	usd
CY2022Q1	us-gaap	Escrow Deposit EscrowDeposit	19694	usd
	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	100000	usd
CY2021Q3	gtch	Stockholders Equitys StockholdersEquitys	50000	usd
CY2022Q2	gtch	Stockholders Equitys StockholdersEquitys	50000	usd
	us-gaap	Derivatives Reporting Of Derivative Activity DerivativesReportingOfDerivativeActivity	<p id="xdx_84F_eus-gaap--DerivativesReportingOfDerivativeActivity_zxyaLCKfdLba" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_863_zXLMs4gWNk3l">Derivative Financial Instruments</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company evaluates all of its agreements to determine if they contain derivatives or have contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value “FV” and is then re-valued at each reporting date, with changes in the FV reported in the statements of operations. For stock-based derivative financial instruments, the Company uses a weighted-average Black-Scholes-Merton option pricing model to value the derivative instruments at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date. As of September, 30, 2022 and December 31, 2021 (audited), the Company’s only derivative financial instrument was an embedded conversion feature associated with convertible notes payable due to certain provisions that allow for a change in the conversion price based on a percentage of the Company’s stock price at the date of conversion.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2022Q3	gtch	Conversion Feature On Convertible Notes ConversionFeatureOnConvertibleNotes	5787760	usd
CY2022Q3	us-gaap	Marketable Securities MarketableSecurities	40942	usd
CY2021Q4	gtch	Conversion Feature On Convertible Notes ConversionFeatureOnConvertibleNotes	10192485	usd
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_848_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zLVz4QM4wqD" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_869_zW81kqiN7yx9">Reclassification</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Certain prior years amounts have been reclassified for consistency with the current period presentation. These reclassifications had no effect on the reported results of operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2022Q1	us-gaap	Deferred Revenue DeferredRevenue	19694	usd
CY2022Q3	us-gaap	Deferred Revenue DeferredRevenue	249159	usd
CY2021Q4	us-gaap	Deferred Revenue DeferredRevenue	249384	usd
CY2022Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	43944	usd
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	0	usd
CY2022Q1	us-gaap	Debt Instrument Annual Principal Payment DebtInstrumentAnnualPrincipalPayment	200000	usd
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	89962	usd
CY2022Q3	us-gaap	Inventory Net InventoryNet	7158	usd
CY2022Q3	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	30049	usd
CY2022Q3	us-gaap	Other Assets Current OtherAssetsCurrent	127169	usd
	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	4088958514	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4089094984	shares
CY2022Q3	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2022Q1	us-gaap	Escrow Deposit EscrowDeposit	19694	usd
CY2022Q3	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.01
	gtch	Escrow Amount Received EscrowAmountReceived	1000000	usd
	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	4200000	usd
CY2022Q1	gtch	Settlement Amount SettlementAmount	3750000	usd
	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	3750000	usd
CY2021Q4	gtch	Services Payable ServicesPayable	33333	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized	200000000	shares
CY2020Q1	gtch	Impairment Charge ImpairmentCharge	5500000	usd
CY2021Q4	gtch	Impairment Charge ImpairmentCharge	15400000	usd
CY2022Q3	us-gaap	Investments Investments	0	usd
CY2021Q4	us-gaap	Investments Investments	0	usd
	us-gaap	Inventory Write Down InventoryWriteDown	0	usd
CY2021	us-gaap	Inventory Write Down InventoryWriteDown	0	usd
CY2022Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	1089143	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	670127	usd
CY2022Q3	gtch	Accounts Payable Related Party Current AccountsPayableRelatedPartyCurrent	530000	usd
CY2021Q4	gtch	Accounts Payable Related Party Current AccountsPayableRelatedPartyCurrent	440000	usd
CY2022Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	660665	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1170088	usd
CY2022Q3	gtch	Accrued Liabilities Stanley AccruedLiabilitiesStanley	660735	usd
CY2021Q4	gtch	Accrued Liabilities Stanley AccruedLiabilitiesStanley	1862928	usd
CY2022Q3	us-gaap	Interest Payable Current InterestPayableCurrent	2914922	usd
CY2021Q4	us-gaap	Interest Payable Current InterestPayableCurrent	2746793	usd
CY2022Q3	gtch	Accrued Interest Related Party Current AccruedInterestRelatedPartyCurrent	46198	usd
CY2021Q4	gtch	Accrued Interest Related Party Current AccruedInterestRelatedPartyCurrent	6327	usd
CY2022Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	5901663	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	6896263	usd
CY2022Q1	us-gaap	Deferred Revenue DeferredRevenue	19694	usd
CY2022Q3	gtch	Accrued Settlement AccruedSettlement	4090057	usd
CY2021Q4	gtch	Accrued Settlement AccruedSettlement	4090057	usd
CY2022Q3	us-gaap	Convertible Debt ConvertibleDebt	6819131	usd
CY2021Q4	us-gaap	Convertible Debt ConvertibleDebt	8424100	usd
CY2022Q3	gtch	Debt Instruments Unamortized Discount Noncurrent DebtInstrumentsUnamortizedDiscountNoncurrent	-269297	usd
CY2021Q4	gtch	Debt Instruments Unamortized Discount Noncurrent DebtInstrumentsUnamortizedDiscountNoncurrent	-278867	usd
CY2022Q3	us-gaap	Other Notes Payable Current OtherNotesPayableCurrent	6574631	usd
CY2021Q4	us-gaap	Other Notes Payable Current OtherNotesPayableCurrent	8145233	usd
CY2022Q3	gtch	Less Current Portion LessCurrentPortion	-6574631	usd
CY2021Q4	gtch	Less Current Portion LessCurrentPortion	-8109436	usd
CY2021Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	35797	usd
	us-gaap	Debt Conversion Converted Instrument Rate DebtConversionConvertedInstrumentRate	0.85	pure
	gtch	Charge Related To Modification Of Debt ChargeRelatedToModificationOfDebt	13777480	usd
	gtch	Convertible Note Payable Description ConvertibleNotePayableDescription	IGOR 1 converted $1,284,600 of the convertible note into 4,185,650 shares of the Company’s common stock. Also, on June 24, 2021, the Company transferred 5,500,000 SURG shares received as repayment of $660,000 of this convertible note.
CY2022Q3	us-gaap	Other Notes Payable Current OtherNotesPayableCurrent	6574631	usd
CY2021Q4	us-gaap	Other Notes Payable Current OtherNotesPayableCurrent	8145233	usd
CY2022Q3	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	1897794	usd
CY2021Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	1547924	usd
CY2022Q3	gtch	Convertible Note Payable To Stanley Hills ConvertibleNotePayableToStanleyHills	116605	usd
CY2021Q4	gtch	Convertible Note Payable To Stanley Hills ConvertibleNotePayableToStanleyHills	116605	usd
CY2022Q3	gtch	Less Current Portion Of Convertible Note Payable LessCurrentPortionOfConvertibleNotePayable	-116605	usd
CY2021Q4	gtch	Less Current Portion Of Convertible Note Payable LessCurrentPortionOfConvertibleNotePayable	-116605	usd
CY2022Q3	gtch	Total Notes Payable TotalNotesPayable	350000	usd
CY2021Q4	gtch	Total Notes Payable TotalNotesPayable	2950000	usd
CY2022Q3	gtch	Current Portion Of Notes Payables CurrentPortionOfNotesPayables	-38196	usd
CY2021Q4	gtch	Current Portion Of Notes Payables CurrentPortionOfNotesPayables	-2612397	usd
CY2022Q3	gtch	Long Term Note Payables LongTermNotePayables	311804	usd
CY2021Q4	gtch	Long Term Note Payables LongTermNotePayables	337603	usd
	gtch	Schedule Of Note Payable Related Parties Table Textblock ScheduleOfNotePayableRelatedPartiesTableTextblock	<table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--ScheduleOfNotePayableRelatedPartiesTableTextblock_zhB7D9ADyzta" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Notes Payable, Non-related Parties and Related Party (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-top: 0; padding-right: 0; text-align: left"><span id="xdx_8BF_zAmyhqFjL47a" style="display: none">Schedule of notes payable related parties</span></td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">September 31,<br/> 2022</span></td> <td style="padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">December 31,<br/> 2021</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 56%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Alpha Eda note payable</span></td> <td style="width: 8%; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td> <td id="xdx_983_ecustom--TotalNotesPayableRelatedParty_c20220930__us-gaap--BusinessAcquisitionAxis__custom--AlphaEdaMember_pp0p0" style="border-bottom: Black 1pt solid; width: 12%; text-align: right" title="Total notes payable"><span style="font: 10pt Times New Roman, Times, Serif">140,000</span></td> <td style="width: 1%; padding-bottom: 1pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="width: 8%; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td> <td id="xdx_986_ecustom--TotalNotesPayableRelatedParty_c20211231__us-gaap--BusinessAcquisitionAxis__custom--AlphaEdaMember_pp0p0" style="border-bottom: Black 1pt solid; width: 12%; text-align: right" title="Total notes payable"><span style="font: 10pt Times New Roman, Times, Serif">140,000</span></td> <td style="width: 1%; padding-bottom: 1pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Less current portion</span></td> <td style="padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td id="xdx_986_ecustom--CurrentPortionOfNotePayableRelatedParties_c20220930_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Less current portion"><span style="font: 10pt Times New Roman, Times, Serif">(140,000</span></td> <td style="padding-bottom: 1pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td> <td style="padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td id="xdx_980_ecustom--CurrentPortionOfNotePayableRelatedParties_c20211231_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Less current portion"><span style="font: 10pt Times New Roman, Times, Serif">(140,000</span></td> <td style="padding-bottom: 1pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Notes payable, net, related party, long-term portion</span></td> <td style="padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td> <td id="xdx_981_ecustom--NotesPayableNetRelatedPartyLongtermPortion_c20220930_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Notes payable, net, related party, long-term portion"><span style="font: 10pt Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1530">—</span></span></td> <td style="padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td> <td id="xdx_98A_ecustom--NotesPayableNetRelatedPartyLongtermPortion_c20211231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Notes payable, net, related party, long-term portion"><span style="font: 10pt Times New Roman, Times, Serif"/> <span style="-sec-ix-hidden: xdx2ixbrl1532">—</span></td> <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/>
CY2022Q3	gtch	Current Portion Of Note Payable Related Parties CurrentPortionOfNotePayableRelatedParties	-140000	usd
CY2021Q4	gtch	Current Portion Of Note Payable Related Parties CurrentPortionOfNotePayableRelatedParties	-140000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2021Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	10192485	usd
	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Issues FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues	191741	usd
	gtch	Fair Value Of Beneficial Conversion Feature Of Debt Converted FairValueOfBeneficialConversionFeatureOfDebtConverted	-1620742	usd
	gtch	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Los FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLos	-3150739	usd
CY2022Q2	us-gaap	Derivative Liabilities DerivativeLiabilities	5612745	usd
	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Issues FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues	134174	usd
	gtch	Fair Value Of Beneficial Conversion Feature Of Debt Converted FairValueOfBeneficialConversionFeatureOfDebtConverted	-314029	usd
	gtch	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Los FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLos	354869	usd
CY2022Q3	us-gaap	Derivative Liabilities DerivativeLiabilities	5787759	usd
CY2021Q4	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1 for 50
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	2000000000	shares
CY2022Q1	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	369198	shares
CY2022Q1	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	35000	usd
CY2022Q2	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	288672073	shares
CY2022Q2	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	1660370	usd
CY2022Q2	gtch	Debt Conversion Converted Instrument Accrued Interest DebtConversionConvertedInstrumentAccruedInterest	6491	usd
CY2022Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	163559	usd
CY2022Q3	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	270300	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	392870	shares
	gtch	Weighted Average Exercise Price Warrants Outstanding Beginning WeightedAverageExercisePriceWarrantsOutstandingBeginning	74.97
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P1Y9M3D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	322100	shares
	us-gaap	Loss Contingency Disclosures LossContingencyDisclosures	<p id="xdx_800_eus-gaap--LossContingencyDisclosures_zKijEdAIJye4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 17 – <span id="xdx_827_zeZIG7Nsm9G4">Contingencies</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Legal Proceedings</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">From time to time, the Company may be involved in various litigation matters, which arise in the ordinary course of business. There is currently no litigation that management believes will have a material impact on the financial position of the Company.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On or around January 30, 2019, RWJ Advanced Marketing, LLC, Greg Bauer, and Warren Jackson sued the Company and multiple third and related parties in Superior Court of the State of California – County of Los Angeles, General District in connection with the acquisition of UGO in September 2017. The case number is 19STCV03320 (the “Original Lawsuit”). The complaint in the Original Lawsuit alleges breach of contract, among other causes of action. The Company answered the complaint and filed a cross-complaint against the plaintiffs in the case and third parties on or around February 15, 2019. On or about September 10, 2020, the Company through its agent of service was “served” with a complaint (the Company contested service) that was filed against the Company and third parties by Robert Warren Jackson and Gregory Bauer in Los Angeles Superior Court Case No.: 20STCV32709 (“Second Lawsuit”). In the Original Lawsuit filed, the court rejected the plaintiff’s claims that they were filing a purported quasi-derivative lawsuit. As such, in this current litigation, the plaintiff is now again claiming the action is a derivative lawsuit. On October 13, 2020, the Second Lawsuit was removed by other defendants into Central District of California (CASE NO. 2:20−cv−09399−RGK−AGR). On February 2, 2021 the Central District of California dismissed the entire Second Lawsuit based on “demand futility”. In the Original lawsuit, the Company filed a cross complaint against the plaintiff and other third parties. The court has scheduled various hearings and a trial date set for December 27, 2021 which was later continued by the Court to September 28, 2022. It was the Company’s intention to dividend its holdings of its wholly owned subsidiary Ugopherservices Corp. (“UGO”). As UGO is the main dispute in the litigations described above, the Company elected to sell UGO to a third-party effective July 1, 2020 (See Note 3). On September 17, 2020, the Company terminated Greg Bauer as consultant (resulting from the sale of UGO), which he confirmed in writing. On or about June 14, 2021 the Company stipulated with plaintiff that all third parties will be released and plaintiff may file a new first amendment complaint that will name only the Company. As such, all third parties other than prior transfer agent of the Company have been dismissed from this litigation. The Company is in default on this note.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Following the sale of UGO, the Company noticed third parties (including SURG, via its asset manager) to wire the UGO funds to its new bank account. SURG never answered the notice. SURG is the clearing house for UGO. The Company noticed certain third parties that it intends to take legal actions to resolve this issue. On November 12, 2020 the Company filed a complaint in the United States District Court – District of Nevada – Case 2:20-cv-02078 against RWJ, Mr. Bauer, Mr. Jackson and against W.L. Petrey Wholesale Company Inc for fraud, breach of contract, Unjust Enrichment and other claims. On January 28, 2022 the court awarded the Company an injunction against RWJ defendants, where all fee funds generating from resale should be deposited into GBT blocked account, and therefore RWJ Defendants cannot use these funds without court order.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company entered into the Confidential Settlement Agreement and Mutual Release (“RJW Agreement”) by and between RWJ Advanced Marketing, LLC, Robert Warren Jackson, Gregory Bauer (collectively the “RJW Parties”) and W.L. Petrey Wholesale Company, Inc., (“Petrey”) on one hand; and GBT Technologies Inc., on behalf of itself and its agents (collectively the GBT Parties”), on the other hand. The Company the RJW Agreement effective September 26, 2022 with final signatures delivered to the Company on or about October 5, 2022. Pursuant to the RJW Agreement, the parties have agreed to settle, release, and otherwise resolve all known or unknown claims between them and agreed to jointly stipulate, move, or otherwise dismiss the lawsuits filed in the United States District Court of Nevada (Case No. 2:20-cv- 02078), in the Superior Court of the State of California, County of Los Angeles, Central District (Case Nos. 19STCV03320 and 20STCV32709), and in the United States District Court of the Central District of California (Case No. 2:20-cv-09399-RGK-AGR) with prejudice. The parties agreed and stipulated to release all funds currently being held in a blocked account of $<span id="xdx_907_eus-gaap--EscrowDeposit_iI_pp0p0_c20220930__us-gaap--TransactionTypeAxis__custom--RWJAgreementMember_z5XdtNREmfJb" title="Escrow amount">19,809</span> with 50% distributed to the RWJ Parties and 50% distributed the Company or its assignee. The Parties also entered into the InComm Assignment Agreement (“IAA”) which assigned, transferred and conveyed all proceeds derived from the RWJ Parties’ agreements with Interactive Communications International, Inc., and its affiliate Hi Technology Corp., including but not limited to that Master Distribution and Service Agreement between Interactive Communications International, Inc. and Petrey d/b/a UGO-HUB dated August 29, 2016, as amended (collectively referred to as the “InComm Proceeds”), and which shall divide the InComm Proceeds 90% to the Company or its assignee and 10% to the RWJ Parties or their assignee. Finally, the Company agreed to pay $<span id="xdx_903_eus-gaap--ProceedsFromRelatedPartyDebt_c20220101__20220930__us-gaap--TransactionTypeAxis__custom--RWJAgreementMember_zy613X0K2Wb5" title="Repayment of debt">40,000</span> to the RWJ Parties or their assignee. The Company accrued $<span id="xdx_90B_eus-gaap--AccruedLiabilitiesAndOtherLiabilities_iI_c20220930__us-gaap--TransactionTypeAxis__custom--RWJAgreementMember_zIjzAXVVPg49" title="Accrued expenses">49,847</span> expenses represent the final amounts due to the RJW Parties.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company under a different settlement agreement with SURG, committed to assign the IAA. As such, on October 5, 2022 and as cumulation of all settlement agreements the Company issued a request to SURG regarding release of certain escrow funds and the execution of an assignment of rights as contemplated in the aforereferenced agreement.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On December 3, 2018, the Company entered into a Securities Purchase Agreement (the “SPA”) with Discover Growth Fund, LLC (the “Investor”) pursuant to which the Company issued a Senior Secured Redeemable Convertible Debenture (the “Debenture”) of $<span id="xdx_909_eus-gaap--DebtInstrumentFaceAmount_c20181203__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredRedeemableConvertibleDebentureMember_pp0p0" title="Note payable, principal amount">8,340,000</span>. In connection with the issuance of the Debenture and pursuant to the terms of the SPA, the Company issued a Common Stock Purchase Warrant to acquire up to <span id="xdx_908_ecustom--WarrantsAquire_c20181203__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredRedeemableConvertibleDebentureMember_pdd" title="Warrants aquire">225,000</span> shares of common stock for a term of three years (the “Warrant”) on a cash-only basis at an exercise price of $100 per share with respect to 50,000 Warrant Shares, $75 with respect to 75,000 Warrant Shares and $50 with respect to 100,000 Warrant Shares. The holder may not exercise any portion of the Warrants to the extent that the holder would own more than 4.99% of the Company’s outstanding common stock immediately after exercise. The outstanding principal amount may be converted at any time into shares of the Company’s common stock at a conversion price equal to 95% of the Market Price less $5 (the conversion price is lowered by 10% upon the occurrence of each Triggering Event – the current conversion price is 75% of the Market Price less $5). The Market Price is the average of the five lowest individual daily VWAP during the period the Debenture is outstanding. On May 28, 2019, the Investor delivered to the Company a “Notice of Default and Notice of Sale of Collateral” (the “Notice”). On December 23, 2019, in arbitration between the Company and the Investor, an Interim Award was entered in favor of the Investor. On January 31, 2020, the Company was informed that a final award was entered (the “Final Award”). The Final Award affirms that certain sections of the Debenture constitute unenforceable liquidated damages penalties and were stricken. Further, it was determined that the Investor was entitled to recovery of their attorney’s fees. Consequently, the arbitrator awarded $<span id="xdx_90C_ecustom--ArbitratorAwarded_pp0p0_c20190501__20190515__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zy2HlhjlB357" title="Arbitrator awarded">4,034,444</span> plus interest of <span id="xdx_906_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20190501__20190515__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_znJYO6OI0fWk" title="Interest rate">7.25</span>% from May 15, 2019 and costs of $<span id="xdx_904_eus-gaap--InterestExpenseOtherDomesticDeposits_pp0p0_c20190501__20190515__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zuJ9qXa5w686" title="Interest">55,613</span>. On February 18, 2020, the Company filed a motion with the United States District Court District of Nevada (the “Nevada Court”) to confirm the Final Award and a motion to consolidate Investor’s application to confirm the Final Award filed in the U.S. District Court of the Virgin Islands (Case No: 3 :20-cv-00012-CVG-RM) (the “Virgin Island Court”). On February 27, 2020, the Nevada Court denied the Company’s motion to confirm the Final Award and motion to consolidate and further decided that the confirmation of the Final Award should be litigated in the Virgin Island Court. As such, on February 27, 2020, the Company filed a Notice of Entry of Order as well as a Motion to Confirm the Arbitration Award, address the outstanding issues regarding whether Investor’s rights are subordinated to other creditors and, thereafter, oversee a commercially reasonable foreclosure sale (Case No: 3 :20-cv-00012-CVG-RM). It was the Company’s position that the final Award must first be confirmed and all questions regarding the rights of Investor relative to those of other creditors must be determined before any foreclosure sale can proceed. It is further the position of the Company that the previously disclosed foreclosure sale scheduled by Investor is being conducted in a commercially unreasonable manner and that if Discover proceeded forward with the foreclosure sale it did so at its own risk. Nevertheless, on February 28, 2020, Investor advised that it conducted a sale of the Company’s assets. As the date of this report Investor failed to present a deed of sale for the alleged sale that allegedly took place as noticed. The Company filed with Virgin Island Court the motions disputing the validity of the alleged sale. On July 28, 2020, Investor filed in the State of Nevada a motion for attorney’s fees $<span id="xdx_90C_eus-gaap--LossContingencyDamagesSoughtValue_c20200701__20200728_pp0p0" title="Sought value">48,844</span> and cost of $<span id="xdx_908_ecustom--LegalCost_c20200701__20200728_pp0p0" title="Legal cost">716</span>. The Company filed an answer on August 11, 2020. On October 16, 2020, Investor motion for attorney’s fees $<span id="xdx_90C_eus-gaap--LossContingencyDamagesSoughtValue_c20201001__20201016_pp0p0" title="Sought value">48,844</span> and cost of $<span id="xdx_904_ecustom--LegalCost_c20201001__20201016_pp0p0" title="Legal cost">716</span> was denied. The balance was included in accounts payable for the unearned settlement. As of September, 30, 2022, this case is still pending with the Federal court and the Court has not taken any substantive action in the matter as of the date of this report.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>GBT Technologies, S.A.</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">On September 14, 2018, the Company entered into an Exclusive Intellectual Property License and Royalty Agreement (the “GBT License Agreement”) with GBT-CR, a fully compliance and regulated crypto currency exchange platform that currently operates in Costa Rica as a decentralized crypto currency platform, pursuant to which, among other things, the Company granted to GBT-CR an exclusive, royalty-bearing right and license relating intellectual property relating to systems and methods of converting electronic transmissions into digital currency as reflected in that certain patent filed with the United Stated Patent and Trademark Office on or about June 14, 2018 (EFS ID: 32893586; Application Number: 16008069; Type: Utility under 35 USC 111(a); Confirmation Number: 6787)(collectively, the “Digital Currently Technology”). Pursuant to the GBT License Agreement, the Company granted GBT-CR an exclusive worldwide license to use the Digital Currency Technology to make, use, sell, lease or otherwise commercialize and dispose of products and devices utilizing the Digital Currently Technology. Under the terms of the GBT License Agreement, the Company is entitled to receive a royalty of 2% of gross revenue of each licensed product sold by GBT-CR during the period starting in which revenue is first generated using the licensed products and continuing for five years thereafter. Upon signing the GBT-CR License Agreement, GBT-CR paid the Company $<span id="xdx_90A_eus-gaap--Revenues_pp0p0_c20180101__20181231__dei--LegalEntityAxis__custom--GBTTechnologiesMember_zWZp7Odxhyx" title="Revenues">300,000</span> which is nonrefundable. The Company has recognized the $300,000 as revenue during the year ended December 31, 2018. Upon GBT-CR making available for sale (the “Commercial Event”) an ICO (Initial Coin Offering) (the “Coin”), GBT-CR will make a payment to the Company of $<span id="xdx_909_ecustom--PaymentForExpenses_pp0p0_c20180101__20181231__dei--LegalEntityAxis__custom--GBTTechnologiesMember_zxpSFEVd3Bpj" title="Payment for expenses">5,000,000</span>. Further, upon the Commercial Event, GBT-CR will grant the Company the ability to acquire 30% of the Coin at a 30% discount of such offering price of the Coin. The GBT License Agreement commenced as of the signing date and, unless terminated in accordance with the termination provisions of the GBT License Agreement, shall remain in force until the expiration of the patent pertaining to the Digital Currency Technology; provided that the right to use trade, secrets shall survive the expiration of the GBT License Agreement provided the Company has not terminated. Prior to the signing of the GBT License Agreement, GBT-CR advanced $<span id="xdx_909_eus-gaap--DeferredRevenue_iI_pp0p0_c20220930__dei--LegalEntityAxis__custom--GBTTechnologiesMember_zCd2b9jAIHya" title="Unearned revenue">200,000</span> to the Company, which the parties agreed will be applied toward the $5,000,000 fee when it becomes due. On February 27, 2020 GBT Technologies, S.A., as successor in interest to Hermes Roll, LLC had notified the Company that it was in default on its Amended and Restated Territorial License Agreement (“ARTLA”) dated June 15, 2015 and that the ARTLA had been cancelled and rescinded.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> On October 18, 2021, the AltCorp Parties, the Company, and SURG entered into a Memorandum of Understanding (the “MOU”) to set up a framework for an attempt to settle the two lawsuits.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On December 22, 2021 (the “Effective Date”), pursuant to the framework in the MOU, the AltCorp Parties (and an additional third party), the Company, ECS, and SURG, Kevin Brian Cox (SURG’s Chief Executive Officer) – in his individual capacity, entered into a Resolution of Purchase, Mutual Release, and Settlement Agreement (the “Final Settlement Agreement”) to settle the two lawsuits and resolve all disputes related to the consideration paid by SURG to the Company in connection with the APA.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On or about July 9, 2021 the Company filed a lawsuit in District Court in Clack County Nevada – Department 19 (Case number A-21-837631-C) against Terry Taylor and TTSG Holdings, Inc for breach of contract, breach of covenant of Good Faith and Fair Dealing, Unjust Enrichment and declaratory relief for failure of providing consulting services per contract they entered. The Company is demanding the return of <span id="xdx_90E_ecustom--ReturnOfSharesIssued_c20210702__20210709_z2nEkB2dxVli" title="Return of shares issued">240,000</span> shares issued, return of the $<span id="xdx_901_ecustom--CancellationOfPayments_c20210702__20210709_pp0p0" title="Cancellation of payments">5,000</span> payments, recission of the consulting agreement, and attorney’s fees and costs. The lawsuit is still pending as of the date of this report. As Terry Taylor and TTSG Holdings failed to appear to a notice of deposition, the Company filed for a summary judgment.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Gregory Mancuso and Rainer AG</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On or about February 2, 2022, GBT was served with a First Amended Complaint (the “Complaint”) initiated by Gregory Mancuso and Rainer AG, a Swiss corporation, Case No. 21SMCV01430, filed in the Superior Court of the State of California for the County of Los Angeles. The Complaint names a number of different parties, including GBT, and asserts, among other things, claims for conversion, unjust enrichment, breach of contract, and breach of implied covenant of fair dealing, which Plaintiffs allege arise out of a brokerage agreement entered into between Plaintiff Rainer AG and co-defendant Consul Group re Dos Mil Veintiuno S.R.L (“Consul”). GBT was sued under an alter ego theory of liability, and its only involvement in the above-referenced chain of events seems to be that its shares were deposited with Rainer by Consul upon the opening of the brokerage account. GBT will be filling a demurrer to the First Amended Complaint based on a variety of deficiencies with the First Amended Complaint, and will ask the Court to dismiss the claims against GBT.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Stock Loan Receivable</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">On January 8, 2019, the Company entered into a Stock Pledge Agreement with Latin American Exchange Latinex Casa de Cambio, S.A., a Costa Rica corporation (“Latinex”), to provide that Latinex may maintain its required regulatory capital as required by various regulators. The Company pledged <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20190101__20190108_zb53LzJQgOfb" title="Restricted shares">4,005</span> restricted shares of its common stock valued at $<span id="xdx_906_eus-gaap--StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_c20190101__20190108_zRWVMxwbqjcc" title="Value of restricted shares">7,610,147</span> (based on the closing price on the grant date) for three years in consideration of an annual payment of $<span id="xdx_90A_ecustom--AnnualPayment_iI_c20190108_zPsCF94z1kE4" title="Annual payment">375,000</span> paid in quarterly installments of $<span id="xdx_903_eus-gaap--DebtInstrumentPeriodicPayment_c20190101__20190108_z6qHJkzDnir5" title="Installment paid">93,750</span>. In lieu of cash payment, Latinex may pay the Company in virtual currency of WISE Network S.A. valued at a 50% discount of its offering price of $10 per token. In the event that Latinex’s required capital has decreased below $<span id="xdx_90C_ecustom--DecreaseInCapital_c20190101__20190108_z3iVxBAnhsag" title="Decrease in capital">5,000,000</span>, Latinex is permitted to sell the pledged shares of common stock only in an amount to ensure that Latinex can satisfy the required capital levels. The Company must consent to such sale of the shares of common stock, which may not be unreasonably withheld. Upon expiration of the agreement, the remaining shares of common stock shall be returned to the Company free and clear of all liens. The Company recorded the value of these shares of common stock as a stock loan receivable which is presented as a contra-equity account in the accompanying consolidated balance sheets. At December 31, 2019, the Company wrote off the accrued interest income as Latinex did not perform any payment and the Company has no mean to enforce this payment. Latinex agreed in principle to return the pledged 4,005 restricted shares to the Company for cancellation. The <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20220101__20220930_z8YVMKkTwmx9" title="Restricted shares">4,005</span> restricted shares have not yet been returned to the Company as of September 30, 2022.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span style="text-decoration: underline">Assignment of lease agreement</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On May 17, 2022, Mahaser LLC (“Assignee”) entered into an assignment and assumption of lease agreement by and between 2819 Coldwater LLC (“Assignor”), Sunset Place Holdings LLC (“Lessor”) and Yossi Attia (“Guarantor”). Pursuant to the agreement, Lessor agreed to lease to Assignor certain Standard Industrial/Commercial Multi-Tenant Lease – Gross agreement dated February 7, 2022 (the “Lease”) and expiring on January 31, 2024, which premises commonly known as 8265 Sunset Boulevard, Suite #107, West Hollywood, CA 90046. The base rent payment shall equal $4,100 per month and share of common area operating expense shall equal $<span id="xdx_905_eus-gaap--OperatingExpenses_c20220501__20220517_zSMAwisQxHS1" title="Operating expense">200</span> per month. Guarantor has guaranteed payment of Assignor’s obligations under the Lease and Assignor assigned all of its right, title and interest in the Lease to Assignee and Assignee assumed Assignor’s obligations under the Lease.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2020Q3	us-gaap	Loss Contingency Damages Sought Value LossContingencyDamagesSoughtValue	48844	usd
CY2020Q3	gtch	Legal Cost LegalCost	716	usd
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	70770	shares
	gtch	Weighted Average Exercise Price Warrants Outstanding End WeightedAverageExercisePriceWarrantsOutstandingEnd	205.07
	gtch	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms1 ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms1	P0Y6M21D
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	70770	shares
	gtch	Weighted Average Exercise Price Warrants Exercisable At End WeightedAverageExercisePriceWarrantsExercisableAtEnd	205.07
	gtch	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercisable Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms	P0Y6M21D
CY2021Q4	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	10000000	usd
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized	200000000	shares
CY2022Q3	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	250000	usd
	gtch	Advanced From Related Party AdvancedFromRelatedParty	634176	usd
	us-gaap	Proceeds From Repayments Of Other Debt ProceedsFromRepaymentsOfOtherDebt	664225	usd
	gtch	Outstanding Payable Balance OutstandingPayableBalance	30049	usd
CY2021	gtch	Outstanding Payable Balance OutstandingPayableBalance	0	usd
CY2020Q4	us-gaap	Loss Contingency Damages Sought Value LossContingencyDamagesSoughtValue	48844	usd
CY2020Q4	gtch	Legal Cost LegalCost	716	usd
CY2021Q3	gtch	Return Of Shares Issued ReturnOfSharesIssued	240000	shares
CY2021Q3	gtch	Cancellation Of Payments CancellationOfPayments	5000	usd
CY2019Q1	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	4005	shares
CY2019Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	7610147	usd
CY2019Q1	gtch	Annual Payment AnnualPayment	375000	usd
CY2019Q1	us-gaap	Debt Instrument Periodic Payment DebtInstrumentPeriodicPayment	93750	usd
CY2019Q1	gtch	Decrease In Capital DecreaseInCapital	5000000	usd
	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	4005	shares
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	200	usd
	us-gaap	Net Income Loss NetIncomeLoss	2255565	usd
	gtch	Gain On Surge Settlement GainOnSurgeSettlement	3012633	usd
	gtch	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss1 FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss1	2795870	usd

Files In Submission

Name	View Source	Status
0001731122-22-001969-index-headers.html	Edgar Link	pending
0001731122-22-001969-index.html	Edgar Link	pending
0001731122-22-001969.txt	Edgar Link	pending
0001731122-22-001969-xbrl.zip	Edgar Link	pending
e4226_10q.htm	Edgar Link	pending
e4226_ex31-1.htm	Edgar Link	pending
e4226_ex32-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
gtch-20220930.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
gtch-20220930_cal.xml	Edgar Link	unprocessable
gtch-20220930_def.xml	Edgar Link	unprocessable
gtch-20220930_lab.xml	Edgar Link	unprocessable
gtch-20220930_pre.xml	Edgar Link	unprocessable
e4226_10q_htm.xml	Edgar Link	completed
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$GTCH
GBT Technologies Inc. Stock $gtch

2022 Q4 Form 10-Q Financial Statement

#000173112222001969 Filed on November 14, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GTCH GBT Technologies Inc. Stock $gtch

2022 Q4 Form 10-Q Financial Statement

#000173112222001969 Filed on November 14, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GTCH
GBT Technologies Inc. Stock $gtch